Serial assessment of the novel biomarker MFGE8 in comparison with GFAP for predicting severity and outcome after traumatic brain injury
Serum MFGE8 is a promising biomarker after TBI. It is closely related to the injury severity and clinical prognosis. Particularly, it demonstrates high prognostic predictive value within 24 h post-injury. Continuous monitoring of MFGE8 may aid in early risk stratification and prognostic assessment for TBI.
Authors
- Defang Luo
- Mingang Zou
- Qianliang Huang (ORCID: https://orcid.org/0000-0003-1293-177X)
- Tao Hong (ORCID: https://orcid.org/0009-0007-8355-2984)
- Zhiji Tang
- Jianshen Zhong
- Qiuhua Jiang
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.3389/fneur.2026.1750940
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.00